Carol F. Boerner, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 130 Pleasant St, Claremont, NH 03743 Phone: 603-542-2002 |
News Archive
National Cancer Institute (NCI) has renewed a $11.5 million Specialized Program of Research Excellence (SPORE) grant in prevention, diagnosis and treatment of ovarian cancer, which supports multidisciplinary research at Fox Chase Cancer Center and the University of Pennsylvania. First approved in 1999, this marks the third five-year term for the Fox Chase-Penn Ovarian SPORE.
In the light of growing concerns about the separation of producers and consumers in our food system and the power of big supermarkets, new research funded by Economic and Social Research Council (ESRC) provides valuable insights into the motivations and practices of consumers and producers involved in ‘alternative food' networks, which include schemes as varied as organic vegetable boxes, community gardens and farm animal adoption.
A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo- and radioresistant mechanisms was by presented by Dr John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital
Technology for a smart mouthguard from the University of Maryland, Baltimore has been licensed by University of Maryland School of Dentistry alumnus Michael Wright, DDS, MS, into his new startup company, The WrightGuard Innovation Corporation.
A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
› Verified 7 days ago